[1]
|
U. K. Narta, S. S. Kanwar and W. Azmi, “Pharmacological and Clinical Evaluation of L-Asparaginase in the Treatment of Leukemia,” Critical Reviews in Oncology/Hematology, Vol. 61, No. 3, 2007, pp. 208-221.
doi:10.1016/j.critrevonc.2006.07.009
|
[2]
|
S. Patil, J. Coutsouvelis and A. Spencer, “Asparaginase in the Management of Adult Acute Lymphoblastic Leukemia: Is It Used Appropriately?” Cancer Treatment Reviews, Vol. 37, No. 3, 2011, pp. 202-207.
doi:10.1016/j.ctrv.2010.08.002
|
[3]
|
J. C. Panetta, A. Gajjar, N. Hijiya, L. J. Hak, C. Cheng, W. Liu, C. H. Pui and M. V. Relling, “Comparison of Native E. coli and PEG-Asparaginase Pharmacokinetics and Pharmacodynamics in Pediatric Acute Lymphoblastic Leukemia,” Clinical Pharmacology and Therapeutics, Vol. 86, No. 6, 2009, pp. 651-658. doi:10.1038/clpt.2009.162
|
[4]
|
M. I. Sarquis, E. M. Oliveira, A. S. Santos and G. L. Costa, “Production of L-Asparaginase by Filamentous Fungi,” Memorias do Instituto Oswaldo Cruz, Vol. 99, No. 5, 2004, pp. 489-492. doi:10.1590/S0074-02762004000500005
|
[5]
|
A. Mishra, “Production of L-Asparaginase, an Anticancer Agent, from Aspergillus niger Using Agricultural Waste in Solid State Fermentation,” Applied Biochemistry and Biotechnology, Vol. 135, No. 1, 2006, pp. 33-42.
doi:10.1385/ABAB:135:1:33
|
[6]
|
C. Drainas and J. A. Pateman, “L-Asparaginase Activity in the Fungus Aspergillus nidulans,” Biochemical Society Transactions, Vol. 41, 1977, pp. 1365-1371.
|
[7]
|
R. Pieters, S. P. Hunger, J. Boos, C. Rizzari, L. Silverman, A. Baruchel, N. Goekbuget, M. Schrappe and Ch.-H. Pui, “L-Asparaginase Treatment in Acute Lymphoblastic Leukemia,” Cancer, Vol. 117, No. 2, 2011, pp. 239-249.
doi:10.1002/cncr.25489
|
[8]
|
A. Imada, S. Igarasi, K. Nakahama and M. Isono, “Asparaginase and Glutaminase Activities of Microorganisms,” Journal Genetics Microbiology, Vol. 76, No. 1, 1973, pp. 85-99.
|
[9]
|
M. Bradford, “A Rapid and Sensitive Method for the Quantification of Microgram Quanties of Protein Utilizing the Principle of Protein Dye Binding,” Analitical Biochemistry, Vol. 72, No. 1-2, 1976, pp. 248-254.
doi:10.1016/0003-2697(76)90527-3
|
[10]
|
A. L. Soares, G. M. Guimar?es, B. Polakiewicz, R. N. M. Pitombo and J. Abrah?o-Neto, “Effects of Polyethylene Glycol Attachment on Physicochemical and Biological Stability of E. coli L-Asparaginase,” International Journal of Pharmaceutics. Vol. 237, No. 1-2, 2002, pp. 163-170. doi:10.1016/S0378-5173(02)00046-7
|
[11]
|
U. K. Laemmli, “Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4,” Nature, Vol. 227, No. 5259, 1970, pp. 680-685.
doi:10.1038/227680a0
|
[12]
|
H. Blum, H. Beier and H. J. Gross, “Improved Silver Staining of Plant Proteins, RNA and DNA in Polyacrylamide Gels,” Electrophoresis, Vol. 8, No.2, 1987, pp. 93-99. doi:10.1002/elps.1150080203
|
[13]
|
R. C. Stong, S. J. Korsmeyer, J. L. Parkin, D. C. Arthur and J. H. Kersey, “Human Acute Leukemia Cell Line with the t(4:11) Chromosomal Rearrangement Exhibits B Lineage and Monocytic Characteristics,” Blood, Vol. 65, No. 1, 1985, pp. 21-31.
|
[14]
|
V. C. Foster and S. Said, “The Influence of Nitrogen Source on L-Asparaginase Production by Strain Isolated from Soil,” VII Seminário Brasileiro de Tecnologia Enzimática, Caxias do Sul, 21-24 May 2006, p. 124.
|
[15]
|
V. I. Avramis and E. H. Panosyan, “Pharmacokinetic/Pharmacodynamic Relationships of Asparaginase Formulations: The Past, the Present and Recommendations for the Future,” Clinical Pharmacokinetics, Vol. 44, No. 4, 2005, pp. 367-393.
|
[16]
|
E. H. Panosyan, R. S. Grigoryan, I. A. Ayramis, N. L. Seibel, P. S Gaynon, S. E. Siegel, H. J. Finger and V. I. Ayramis, “Deamination of Glutamine Is a Prerequisite for Optimal Asparagine Deamination by Asparaginases in Vivo (CCG-1961),” Anticancer Research, Vol. 24, No. 2C, 2004, pp. 1121-1125.
|
[17]
|
G. Ollenschlager, E. Roth, W. Linkescht, S. Jansen, A. Simmel and B. Modder, “Asparaginase-Induced Derangements of Glutamine Metabolism: The Pathogenetic Basis for Some Drug-Related Side-Effects,” European Journal of Clinical Investigation, Vol. 18, No. 5, 1988, pp. 512-516. doi:10.1111/j.1365-2362.1988.tb01049.x
|
[18]
|
M. N. Offman, M. Krol, N. Patel, S. Krishnan, J. Z. Liu, V. Saha and P. A. Bates, “Rational Engineering of L-Asparaginase Reveals Importance of Dualactivity for Cancer Cell Toxicity,” Blood, Vol. 117, No. 5, 2011, pp. 1614-1621. doi:10.1182/blood-2010-07-298422
|
[19]
|
A. M. Aslanian, B. S. Fletcher and M. S. Kilberg, “Asparagine Synthetase Expression Alone Is Sufficient to Induce L-Asparaginase Resistance in MOLT-4 Human Leukaemia Cells,” Biochemical Journal, Vol. 357, No. Pt 1, 2001, pp. 321-328. doi:10.1042/0264-6021:3570321
|
[20]
|
A, M. Aslanian and M. S. Kilberg, “Multiple Adaptive Mechanisms Affect Asparagine Synthetase Substrate Availability in Asparaginase-Resistant MOLT-4 Leukaemia Cells,” Biochemical Journal, Vol. 358, No. Pt1, 2001 pp. 59-67. doi:10.1042/0264-6021:3580059
|